105 related articles for article (PubMed ID: 29236891)
1. High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.
Tirapelli DPDC; Lustosa IL; Menezes SB; Franco IM; Rodrigues AR; Peria FM; Marinho AMDN; Serafini LN; Carlotti CG; Tirapelli LF
Arq Neuropsiquiatr; 2017 Dec; 75(12):875-880. PubMed ID: 29236891
[TBL] [Abstract][Full Text] [Related]
2. Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).
Li J; Tang H; Zhang Y; Tang C; Li B; Wang Y; Gao Z; Luo P; Yin A; Wang X; Cheng G; Fei Z
PLoS One; 2013; 8(11):e81258. PubMed ID: 24278406
[TBL] [Abstract][Full Text] [Related]
3. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
4. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3.
Ray SK; Patel SJ; Welsh CT; Wilford GG; Hogan EL; Banik NL
J Neurosci Res; 2002 Jul; 69(2):197-206. PubMed ID: 12111801
[TBL] [Abstract][Full Text] [Related]
5. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
Chen GG; Sin FL; Leung BC; Ng HK; Poon WS
J Cell Physiol; 2005 Apr; 203(1):127-32. PubMed ID: 15493013
[TBL] [Abstract][Full Text] [Related]
7. Nonlinear regulation of commitment to apoptosis by simultaneous inhibition of Bcl-2 and XIAP in leukemia and lymphoma cells.
Skommer J; Das SC; Nair A; Brittain T; Raychaudhuri S
Apoptosis; 2011 Jun; 16(6):619-26. PubMed ID: 21442307
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme.
Blahovcova E; Richterova R; Kolarovszki B; Dobrota D; Racay P; Hatok J
Int J Mol Med; 2015 Dec; 36(6):1677-84. PubMed ID: 26459752
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
Fulda S; Meyer E; Debatin KM
Oncogene; 2002 Apr; 21(15):2283-94. PubMed ID: 11948412
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
[TBL] [Abstract][Full Text] [Related]
12. Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme.
Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC
Mol Med Rep; 2013 Jan; 7(1):139-43. PubMed ID: 23076250
[TBL] [Abstract][Full Text] [Related]
13. Caspase-3 and Bcl-2 expression in glioblastoma: an immunohistochemical study.
Tirapelli LF; Bolini PH; Tirapelli DP; Peria FM; Becker AN; Saggioro FP; Carlotti CG
Arq Neuropsiquiatr; 2010 Aug; 68(4):603-7. PubMed ID: 20730317
[TBL] [Abstract][Full Text] [Related]
14. Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.
Yang W; Cooke M; Duckett CS; Yang X; Dorsey JF
Cell Cycle; 2014; 13(6):992-1005. PubMed ID: 24552816
[TBL] [Abstract][Full Text] [Related]
15. Targeting apoptosis pathways in glioblastoma.
Eisele G; Weller M
Cancer Lett; 2013 May; 332(2):335-45. PubMed ID: 21269762
[TBL] [Abstract][Full Text] [Related]
16. Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme.
Ruggieri S; Tamma R; Marzullo A; Annese T; Marinaccio C; Errede M; Susca FC; Senetta R; Cassoni P; Vacca A; Albano F; Saracino C; Notarangelo A; Specchia G; Ribatti D; Nico B
Cancer Lett; 2014 Oct; 353(1):41-51. PubMed ID: 25038272
[TBL] [Abstract][Full Text] [Related]
17. Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis.
Edison N; Curtz Y; Paland N; Mamriev D; Chorubczyk N; Haviv-Reingewertz T; Kfir N; Morgenstern D; Kupervaser M; Kagan J; Kim HT; Larisch S
Cell Rep; 2017 Oct; 21(2):442-454. PubMed ID: 29020630
[TBL] [Abstract][Full Text] [Related]
18. Gene expression study related with the intrinsic pathway of apoptosis in bladder cancer by real-time PCR technique.
Barione DF; Lizarte FS; Novais PC; de Carvalho CA; Valeri FC; Peria FM; de Oliveira HF; Zanette DL; Silva WA; Cologna AJ; Reis RB; Tucci S; Martins AC; Tirapelli DP; Tirapelli LF
Genet Mol Res; 2013 Apr; 12(2):878-86. PubMed ID: 23613234
[TBL] [Abstract][Full Text] [Related]
19. Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation.
Maas C; Verbrugge I; de Vries E; Savich G; van de Kooij LW; Tait SW; Borst J
Cell Death Differ; 2010 Oct; 17(10):1613-23. PubMed ID: 20395960
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner.
Soubéran A; Cappaï J; Chocry M; Nuccio C; Raujol J; Colin C; Lafitte D; Kovacic H; Quillien V; Baeza-Kallee N; Rougon G; Figarella-Branger D; Tchoghandjian A
Stem Cells; 2019 Jun; 37(6):731-742. PubMed ID: 30920104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
